It's always interesting to look at the language used in these reports, isn't it? To quote from this article (and not necessarily the people actually being quoted)...
"As a result, a generic version of Sovaldi — the first of the new crop of hepatitis C medications to revolutionize treatment — could become available in Europe in 2024 instead of 2028, according to Tahir Amin, the who heads intellectual property at IMAK, the Initiative for Medicines, Access & Knowledge, a nonprofit that works with patient advocacy groups in challenging patents."
"A Gilead spokesman sent us a statement maintaining the patent, as a whole, was not revoked. “The European Patent Office “confirmed that Sovaldi was covered by a valid European patent,” he wrote us. The patent office “found that claims covering [Sovaldi] within the patent were valid. The board believed that these claims were novel and inventive.” He also insisted there will be no impact on the possibility of generics arriving before 2028."
Hmmm, ... lets just pick out two key phrases: "could become available in Europe in 2024 instead of 2028" ... and "no impact on the possibility of generics arriving before 2028"
While technically this analysis might be be correct, to properly report on the real situation it should be qualified (but isn't) with the words "through corporate sources."
So the corporate propaganda (that they control the market) continues as usual, and as usual ignores the fact that equivalent generic medications are available now through personal importation provisions in the USA and many european countries....
So, yes, I totally agree, THE FIXHEPC SHOW MUST GO ON!
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog.
Started Sof+Dac from fixHepC 10-Nov-2015. NO sides.
Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000.
Week4: AST 47, ALT 58. VL < 15 (unquantifiable).
Week12 (EOT): AST 30, ALT 26, VL UND
Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND
Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND
Ever grateful to Dr James.
Relapsed somewhere after all that... Bummer!
Jan 2018: VL 63 000 (still GT3).